Non-viral gene delivery: From the needle to the nucleus

Expert Opinion on Biological Therapy

Volumn 7, Issue 6, 2007, Pages 799-808

  Rettig, Garrett R ^a   Rice, Kevin G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Endosomal escape; Gene therapy; In vivo; Non viral; Nuclear localization; Receptor targeting; Systemic delivery

Indexed keywords

DNA; NANOPARTICLE;

CELL NUCLEUS; CELL NUCLEUS MEMBRANE; GENETIC TRANSFECTION; HUMAN; IN VIVO STUDY; NEEDLE; NONVIRAL GENE DELIVERY SYSTEM; QUANTITATIVE ANALYSIS; REVIEW;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; CELL NUCLEUS; DENDRIMERS; DNA; ENDOCYTOSIS; ENDOSOMES; GENES, REPORTER; HUMANS; LIPIDS; LUCIFERASES; NANOPARTICLES; PROTEINS; REPRODUCIBILITY OF RESULTS; TRANSFECTION;

EID: 34250705236     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.7.6.799     Document Type: Review

References (64)

1. MANCHENO-CORVO P, MARTIN-DUQUE P: Viral gene therapy. Clin. Trans. Oncol. (2006) 8(12):858-867.
2. FIRE A, XU S, MONTGOMERY MK et al.: Potent and specific genetic interference by double-sttanded RNA in Caenorhabditis elegans. Nature (1998) 391(6669):806-811. •• Novel prize winning discovery that transformed the gene therapy field. The use of siRNA to knock down protein expression is a new major branch of gene therapy
3. KONOPKA K, FALLAH B, MONZON-DULLER J, OVERLID N, DUZGUNES N: Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk/ganciclovir-mediated cytotoxicity. Cell. Mol. Biol. Lett. (2005) 10(3):455-470.
4. PIETERSZ GA, TANG C-K, APOSTOLOPOULOS V: Structure and design of polycationic carriers for gene delivery. Mini Rev. Med. Chem. (2006) 6(12):1285-1298.
5. GODBEY WT, WU KK, MIKOS AG: Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA. (1999) 96(9):5177-5181.
6. ABDALLAH B, HASSAN A, BENOIST C et al.: A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum. Gene Ther. (1996) 7(16):1947-1954.
7. ZELPHATI O, SZOKA FC JR: Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm. Res. (1996) 13(9):1367-1372.
8. GOLDMAN CK, SOROCEANU L, SMITH N et al.: In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer. Nat. Biotechnol. (1997) 15(5):462-466.
9. KUKOWSKA-LATALLO JF, BIELINSKA AU, JOHNSON J et al.: Efficient transfer of genetic material into mammalian cells using starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. USA (1996) 93:4897-4902.
10. REJMAN J, OBERLE V, ZUHORN IS, HOEKSTRA D: Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J. (2004) 377(1):159-169.
11. REJMAN J, CONESE M, HOEKSTRA D: Gene transfer by means of lipo- and polyplexes: role of clathrin and caveolae-mediated endocytosis. J. Liposome Res. (2006) 16(3):237-247.
12. TAKESHITA S, GAL D, LECLERC G et al.: Increased gene expression after liposome-mediated atterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J. Clin. Invest. (1994) 93(2):283-291.
13. FASBENDER A, ZABNER J, ZEIHER BG, WELSH MJ: A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia. Gene Ther. (1997) 4(11):1173-1180.
14. WADHWA MS, KNOELL DL, YOUNG AP, RICE KG: Targeted gene delivery with a low molecular weight glycopeptide carrier. Bioconjug. Chem. (1995) 6(3):283-291.
15. BELLOCQ NC, PUN SH, JENSEN GS, DAVIS ME: Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug. Chem. (2003) 14(6):1122-1132.
16. PLANK C, ZATLOUKAL K, COTTEN M, MECHTLER K, WAGNER E: Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjug. Chem. (1992) 3:533-539.
17. GOTTSCHALK S, CRISTIANO RJ, SMITH LC, WOO SL: Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Ther. (1994) 1(3):185-191.
18. WOLFERT MA, SEYMOUR LW: Chloroquine and amphipathic peptide helices show synergistic transfection in vitro. Gene Ther. (1998) 5(3):409-414.
19. BOUSSIF O, LEZOUALC'H F, ZANTA MA et al.: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA (1995) 92(16):7297- 7301. •• An extremely important discovery providing an important benchmark gene transfer polymer that works universally to transform nearly all cell types with excellent efficiency.
20. BEHR JP: The proton sponge, a means to enter cells viruses never thought of. Med. Sci. (1996) 12:56-58.
21. PLANK C, OBERHAUSER B, MECHTLER K, KOCH C, WAGNER E: The influence of endosome-disruptive peptides on gene transfer using synthetic. J. Biol. Chem. (1994) 269(17 (29 Apr)):12918-12924. • One of the earliest examples of the use of fusogenic peptide to increase gene transfer in vitro.
22. ZANTA MA, BELGUISE-VALLADIER P, BEHR JP: Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. (1999) 96:91-96. • A very early study that indicated that a nuclear localizing peptide could increase gene transfer efficiency.
23. ALAM J, COOK JL: Reporter genes: application to the study of mammalian gene transcription. Anal. Biochem. (1990) 188:245-254.
24. HEIDEL J, MISHRA S, DAVIS ME: Gene Therapy and Gene Delivery Systems: Molecular Conjugates (Ed.), Springer Berlin/Heidelberg, Heidelberg (2005):7-39.
25. MCKENZIE D, SMILEY B, KWOK KY, RICE KG: Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconj. Chem. (2000) 11:901-911.
26. DASH PR, READ ML, BARRETT LB, WOLFERT MA, SEYMOUR LW: Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther. (1999) 6:643-650.
27. NOMURA T, KOREEDA N, YAMASHITA F, TAKAKURA Y, HASHIDA M: Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors. Pharm. Res. (1998) 15(1):128-132.
28. BRANNON-PEPPAS L, BLANCHETTE JO: Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. (2004) 56(11):1649-1659.
29. READ ML, SINGH S, AHMED Z et al.: A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res. (2005) 33(9):e86.
30. KWOK KY, YANG Y, RICE KG: Evolution of cross-linked non-viral gene delivery systems. Curr. Opin. Mol. Ther. (2001) 3(2):142-146.
31. YANG Y, PARK Y, MAN S, LIU Y, RICE KG: Cross-linked low molecular weight glycopeptide mediated gene delivery: relationship between DNA metabolic stability and the level of transient gene expression in vivo. J. Pharm. Sci. (2001) 90:2010-2022.
32. TAKAKURA Y, TAKAGI T, HASHIGUCHI M et al.: Characterization of plasmid DNA binding and uptake by peritoneal macrophages from class A scavenger receptor knockout mice. Pharm. Res. (1999) V16(4):503-508.
33. HISAZUMI J, KOBAYASHI N, NISHIKAWA M, TAKAKURA Y: Significant role of liver sinusoidal endothelial cells in hepatic uptake and degradation of naked plasmid DNA after intravenous injection. Pharm. Res. (2004) 21(7):1223-1227.
34. LI S, TSENG WC, STOLZ DB et al.: Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther. (1999) 6(4): 585-594.
35. READ ML, LOGAN A, SEYMOUR LW: Barriers to gene delivery using synthetic vectors. In: Advances in Genetics. Hall JC et al. (Eds), Academic Press (2005):19-46.
36. ISHIDA T, ICHIHARA M, WANG X et al.: Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J. Control Release (2006) 112(1):115-125.
37. BLESSING T, KURSA M, HOLZHAUSER R, KIRCHEIS R, WAGNER E: Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconj. Chem. (2001) 12:529-537.
38. SUDIMACK J, LEE RJ: Targeted drug delivery via the folate receptor. Adv. Drug. Deliv. Rev. (2000) 41(2):147-162.
39. MARTIN ME, RICE KG: Peptide-guided gene delivery. AAPS J. (2007) 9(1):E18-E29.
40. WU GY, WU CH: Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. Biochemistry (1988) 27(3):887-892.
41. WU GY, WU CH: Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. (1988) 263(29 (15 October)):14621-14624. •• One of the earliest examples of target gene delivery. Classical studies that utilized the asialoglycoprotein receptor as a model.
42. FRISCH B, CARRIERE M, LARGEAU C et al.: A new triantennary galacrose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cells. Bioconjug. Chem. (2004) 75(4):754-764.
43. KWOK KY, PARK Y, YONGSHENG Y, MCKENZIE DL, RICE KG: In vivo gene transfer using sulfhydryl crosslinked PEG-peptide/glycopeptide DNA co-condensates. J. Pharm. Sci. (2003) 92(6):1174-1185.
44. MORIMOTO K, NISHIKAWA M, KAWAKAMI S et al.: Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. Mol. Ther. (2003) 7(2):254-261.
45. HILDEBRANDT IJ, IYER M, WAGNER E, GAMBHIR SS: Optical imaging of transferrin targeted PEI/DNA complexes in living subjects. Gene Ther. (2003) 10(9):758-764.
46. COLLARD WT, YANG Y, KWOK KY, PARK Y, RICE KG: Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol peptide DNA co-condensates. J. Pharm. Sci. (2000) 89(4):499-512.
47. LUNGWITZ U, BREUNIG M, BLUNK T, GOPFERICH A: Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. (2005) 60(2):247-266.
48. PARENTE RA, NIR S, SZOKA FC JR: Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry (1990) 29(37):8720-8728.
49. OGRIS M, CARLISLE RC, BETTINGER T, SEYMOUR LW: Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors. J. Biol. Chem. (2001) 276(50):47550-47555.
50. BOECKLE S, FAHRMEIR J, ROEDL W, OGRIS M, WAGNER E: Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexes. J. Control Release (2006) 112(2):240-248.
51. HATAKEYAMA H, AKITA H, KOGURE K et al.: Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther. (2007) 14(1):68-77.
52. CHEN C-P, KIM J-S, STEENBLOCK E, LIU D, RICE KG: Gene transfer with poly-melittin peptides. Bioconjug. Chem. (2006) 17(4):1057-1062.
53. VAUGHAN EE, DEAN DA: Intracellular ttafficking of plasmids during transfection is mediated by microtubules. Mol. Ther. (2006) 13(2):422-428.
54. BREMNER KH, SEYMOUR LW, LOGAN A, READ ML: Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconjug. Chem. (2004) 15(1):152-161.
55. YOUNG JL, BENOIT JN, DEAN DA: Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature. Gene Ther. (2003) 10(17):1465-1470.
56. WANNENES F, CIAFRE SA, NIOLA F, FRAJESE G, FARACE MG: Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo. Cancer Gene Ther. (2005) 12:926-934.
57. ALTON EW, STERN M, FARLEY R et al.: Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 353(9157): 947-954.
58. MADHUSUDAN S, TAMIR A, BATES N et al.: A multicentet Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-Iipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene. Clin. Cancer Res. (2001) 10(9):2968-2996.
59. AL-DOSARI MS, KNAPP JE, LIU D: Hydrodynamic delivery. In: Advances in Genetics. Academic Press (2005):65-82.
60. CONTAG CH, BACHMANN MH: Advances in in vivo bioluminescence imaging of gene expression. Ann. Rev. Biomed. Eng. (2002) 4:235-260.
61. RETTIG G, MCANUFF M, KIM J, LIU D, RICE KG: Quantitative bioluminscence imaging of transgene expression in vivo. Anal. Biochem. (2006) 335:90-94.
62. ZHANG G, BUDKER V, WOLFF JA: High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. (1999) 10(10):1735-1737.
63. LIU F, SONG Y, LIU D: Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. (1999) 6(7):1258-1266. •• A major discovery along with Zhang (above) that established that a small dose of DNA could mediate therapeutic levels of gene expression.
64. PERGOLIZZI RG, JIN G, CHAN D et al.: Correction of a murine model of von Willebrand disease by gene transfer. Blood (2006) 108(3):862-869.